Lightning Flashes As Boston Scientific Takes Over Penumbra For $14.5 Billion
Investors·2026-01-15 16:03

Boston Scientific (BSX) will buy Penumbra (PEN) for $14.5 billion, or $374 a share, the medtechs announced before the open. The move expand Boston Scientific's cardiovascular reach. Boston Sci shares fell before the open while Penumbra stock jumped. Penumbra specializes in mechanical thrombectomy and neurovascular fields, with products to treat pulmonary embolism, stroke, deep vein thrombosis, acute limb ischemia, heart… ...